Immune activation and inflammation play significant roles in the pathogenesis of Alzheimer's disease (AD). To test whether AD patients showed systemic manifestations of inflammation, blood from 41 patients with early stages of AD and 31 aged-match elderly controls were evaluated. Cellular markers for monocyte/macrophage (MO) activation and CD8 T lymphocyte were increased in early AD patients. Expression of monocyte CCR2, the receptor for monocyte chemoattractant protein-1 (MCP-1), was decreased; however, plasma MCP-1 levels were significantly increased and were related to the degree of MO activation in AD. These findings suggest that AD pathogenesis may be influenced by systemic immunologic dysfunction and provides potential immunologic targets for therapeutic intervention.
Introduction
Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by progressive impairment of memory and cognitive function leading to dementia. There are currently more than 5 million Americans afflicted with this disease, which has also become the seventh leading cause of death in this country (Galluzzi et al., 2010) . In AD, brains are characterized by the presence of neurofibrillary tangles, prominent activation of a local inflammatory response and accumulation of β-amyloid into amyloid plaques. Apart from brain-specific changes, an increasing number of studies in AD have reported alterations in systemic immune responses including changes in lymphocyte and macrophage distribution and activation, the presence of autoantibodies, or abnormal inflammatory factors and cytokine production (Kusdra et al., 2000; Galimberti et al., 2006; Mruthinti et al., 2006; Speciale et al., 2007; Pellicano et al., 2010; Hochstrasser et al., 2011; Kim et al., 2011; Parker et al., 2013; Pellicano et al., 2012) . Earlier studies on blood specimens from patients with AD also found elevated levels of plasma lipopolysaccharide (LPS), a potent inflammatory stimulus, and the degree of this elevation was directly related to levels of abnormally activated blood monocyte/macrophages (MO) in AD patients (Zhang et al., 2009 ). Most recently, Zhang et al. reported increased expression of Toll-like receptor 2 (TLR2) and TLR4 on peripheral blood mononuclear cells from AD patients (Zhang et al., 2012) ; both TLRs play a key role in inflammatory neurodegeneration binding the highly hydrophobic amyloid peptides or LPS in AD (Tahara et al., 2006; Walter et al., 2007; Udan et al., 2008) . Together these data have led to the speculation that AD might be a systemic inflammatory disorder resulting in cognitive dysfunction associated changes in the CNS.
Although many studies implicate inflammation and systemic immune dysfunction in AD, little is known about how systemic immune abnormalities relate to AD pathogenesis. The present study was undertaken to determine the extent of cellular and plasma immunologic abnormalities in patients with early stages of AD. Immunophenotypic analyses and measurements of plasma cytokine and immunoglobulin levels were used to identify the degree of immune activation in T-cell and monocyte subsets as well as in plasma from patients with early AD as compared to elderly controls. We report here evidence for significant immunologic abnormalities in the blood of patients with early AD.
Materials and methods

Subjects
Forty-one patients diagnosed with AD (24 females and 17 males; age range: 58-91 years, mean 77.9 ± 7.7) at the Forbes Norris MDA/ ALS Research Center (San Francisco, California, USA) had blood drawn in accordance with the CPMC (California Pacific Medical Center, San Francisco, California, USA) and UCSF committees on human Journal of Neuroimmunology 256 (2013) 38-42 
